We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 381

US health regulator issues new warning for Invokana diabetes drug
  • Leigh Day
  • USA, United Kingdom
  • October 3 2018

Invokana is an oral medication made by Janssen Pharmaceuticals (a division of Johnson & Johnson) prescribed for patients suffering from Type 2


New warnings about silicone breast implants dismissed by the FDA
  • Penningtons Manches LLP
  • USA, United Kingdom
  • September 25 2018

The Food and Drug Administration (FDA) in the US has pushed back on a recent study that suggests that there is an association between silicone breast


Want to have your cake and eat it? Reformulate!
  • Barker Brettell LLP
  • United Kingdom
  • September 20 2018

New regulations, recent government policies and consumer demand are putting pressure on the food and drink manufacturing industry to make healthier


Different types of CAR-T
  • Bristows
  • USA, United Kingdom
  • August 14 2018

CAR-T cell therapy remains an exciting area in healthcare, and a potentially very lucrative one - a recent market study has estimated the value to be


US talc litigation has important lessons for UK insurers
  • RPC
  • USA, United Kingdom
  • August 2 2018

Although it is unlikely litigation involving household staples such as talcum powder could succeed in the UK, the on-going US litigation underlines a


Pharmaceuticals and Brexit: Keeping the industry healthy
  • Linklaters LLP
  • United Kingdom, European Union
  • June 19 2018

It is estimated that each month 37 million packs of medicines are supplied from European countries to the UK with 45 million heading in the other


Life Sciences International Review Q2 2018
  • Morgan Lewis
  • USA, United Kingdom, European Union, France
  • June 6 2018

The most-significant recent development is the entry into force on 25 May of the EU General Data Protection Regulation. This new legislation will have


How do you protect the IP of 3D printed drugs and medical devices?
  • Marks & Clerk
  • USA, United Kingdom
  • February 15 2018

3D printing - also known as additive manufacturing - is set to revolutionise a large number of industries, allowing for innovative product designs and


UK retailers remove baby sleep positioners from sale
  • Leigh Day
  • United Kingdom
  • October 9 2017

Leading UK retailers have halted the sale of baby sleep positioners following a warning from the US Food and Drug Administration, the FDA, that the


UK MHRA Issues New Guidance on Human Factors and Usability Engineering for Medical Devices
  • Hogan Lovells
  • United Kingdom, European Union
  • September 22 2017

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published new guidance on taking human factors into account when designing